You have read all your free articles, to continue reading subscribe to read the rest of this content.
All subjects have been enrolled and dosed in the second and pivotal Phase 3 trial to confirm the clinical efficacy and safety of dasiglucagon for the rescue treatment of severe hypoglycemia in patients with type 1 diabetes. Dasiglucagon is a soluble glucagon analog invented and developed by ZealaAlready a subscriber…
The company announces results from its phase I/II trial of ONCOS-102 in mesothelioma, in combination with standard of care chemotherapy, in which clinical responses were observed in three out of the first six patients. The trial is a randomized phase I/II open label trial, with a six-patient safeAlready a subscriber…
AstraZeneca provides an update on its Immuno-Oncology (IO) late-stage clinical development programme in 1st-line non-small cell lung cancer (NSCLC), including a refinement of the Phase III MYSTIC trial. The MYSTIC trial was initially designed to assess the benefit of durvalumab monotherapy and duAlready a subscriber Login You have read all…
A study conducted at Lund University by lead researcher Charlotte Erlanson-Albertsson, MD, PhD found that people who were trying to lose weight and used the spinach extract Appethyl daily lost more than 40 percent more weight than those who took a placebo. In this clinical trial, overweight womeAlready a subscriber Login…
